Streetbeat News

Analyst Ratings

INTC

Goldman Sachs has reaffirmed its Sell rating on Intel Corporation (NASDAQ:INTC) but increased its price target from $34.00 to $39.00. Despite the raised target, the new price still suggests a potential downside of 9.9% from Intel's current share price of $43.28. Intel is a major chipmaker, leading in the PC and server CPU markets and expanding into new areas like automotive and IoT. The company is also moving towards an outsourced foundry model.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:00 pm

TMUS

T-Mobile US (NASDAQ:TMUS) has been reviewed by 11 analysts in the last three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target is $183.45, up from $175.86, with a high of $200.00 and a low of $168.00. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. T-Mobile US has shown solid revenue growth, a strong net margin, and efficient asset use, but a below-average return on equity. The company's debt-to-equity ratio is below the industry average, indicating a healthier balance sheet.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:00 pm

RJF

Morgan Stanley has maintained its Equal-Weight rating on Raymond James Financial (NYSE:RJF) and increased its price target from $106.00 to $113.00. RJF's shares are currently trading at $113.22, which is slightly above the new target. Raymond James Financial is a financial holding company with over $1.2 trillion in assets under administration as of September 2023, primarily in the U.S. and within its wealth-management segment.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:00 pm

TFII

RBC Capital analyst Walter Spracklin has reiterated an Outperform rating on TFI International (NYSE:TFII) and maintained a price target of $155. The reaffirmation of the positive outlook and price target suggests confidence in the company's performance and potential for stock appreciation.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:59 pm

OMI

UBS analyst Kevin Caliendo has maintained a Buy rating on Owens & Minor (NYSE:OMI) but has reduced the price target from $28 to $26.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:54 pm

MUR

UBS analyst Josh Silverstein has maintained a Neutral rating on Murphy Oil (NYSE:MUR) but has reduced the price target from $45 to $43.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:52 pm

BE

Bloom Energy Corp (NYSE:BE) shares dropped after BofA Securities analyst Julien Dumoulin-Smith downgraded the stock from Neutral to Underperform and cut the price target from $16 to $10. The downgrade was due to low visibility into the company's orders and conversions, with revenue growth expected to be flat for 2023-2025. The company's recent change in COO and uncertainties regarding achieving FY23 targets and 2024 growth were also concerns. Additionally, potential risks to the hydrogen outlook could affect future sales, as per the analyst.

Portfolio Pulse from Priya Nigam

January 29, 2024 | 4:50 pm

IVZ

UBS analyst Brennan Hawken has maintained a Neutral rating on Invesco (NYSE:IVZ) and reduced the price target from $18 to $17.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:46 pm

AMGN

UBS analyst Colin Bristow has maintained a Neutral rating on Amgen (NASDAQ:AMGN) and reduced the price target from $315 to $314.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:44 pm

AHCO

UBS analyst Whit Mayo has maintained a Buy rating on AdaptHealth (NASDAQ:AHCO) but has reduced the price target from $10 to $9.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:42 pm